Preclinical Development of Orally Inhaled Drugs (OIDs)—Are Animal Models Predictive or Shall We Move Towards In Vitro Non-Animal Models?

SIMPLE SUMMARY: This commentary focuses on the methods currently available to test the efficacy and safety of new orally inhaled drugs for the treatment of uncurable respiratory diseases, such as chronic obstructive pulmonary disease (COPD), cystic fibrosis or lung cancer, prior to entering human ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Movia, Dania, Prina-Mello, Adriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460012/
https://www.ncbi.nlm.nih.gov/pubmed/32722259
http://dx.doi.org/10.3390/ani10081259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460012/
https://www.ncbi.nlm.nih.gov/pubmed/32722259
http://dx.doi.org/10.3390/ani10081259

Ejemplares similares